HEM:CC Message Board Post 10434282 | Hemostemix Inc.
home / stock / hem:cc / hem:cc message board
traderquine
()
Posted on: May/05/2023 09:42:21
Hemostemix got the World Economic Forum's Technology Pioneer Award for their revolutionary autologous stem cell therapy platform. $HEM has a solid position in the health care sector, and its 52-week high price was $0.42, indicating how strong the stock is on the TSXV.
News, Short Squeeze, Breakout and More Instantly...
Hemostemix Inc. Company Name:
HEM:CC Stock Symbol:
Market:
-
Calgary, Alberta--(Newsfile Corp. - June 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it was notified by the World Intellectual Property Organization that it was granted the trademark Your Fountain of Youth by the Swiss Trademark Office. "In four h...
-
2024-06-03 13:23:23 ET In a press release this morning, %Hemostemix Inc. (TSXV: $HEM) (OTC: $HMTXF) announced it had signed a Letter of Intent ("LOI") with CytoImmune Therapeutics. The LOI will re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art clinical cell manu...
-
Calgary, Alberta--(Newsfile Corp. - June 3, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce it has signed a Letter of Intent ("LOI") with CytoImmune Therapuetics ("CytoImmune") to re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art c...